These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 122990)

  • 1. Studies on the synthetic capacity and antigenic expression of glutaraldehyde-fixed target cells.
    Bubbers JE; Henney CS
    J Immunol; 1975 Mar; 114(3):1126-31. PubMed ID: 122990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of lymphocyte cytotoxicity by modification of the effector or target cells with periodate or with neuraminidase and galactose oxidase.
    Novogrodsky A
    J Immunol; 1975 Mar; 114(3):1089-93. PubMed ID: 163281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell-mediated cytotoxicity against trinitrophenyl-modified cells: effect of glutaraldehyde treatment on the immunogenicity and antigenicity of trinitrophenyl-modified cells.
    Forman J
    J Immunol; 1977 May; 118(5):1755-62. PubMed ID: 404357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on T cell clonal expansion. I. Suppression of killer T cell production in vivo.
    Kamat R; Henney CS
    J Immunol; 1975 Dec; 115(6):1592-8. PubMed ID: 810513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-stimulated glutaraldehyde-fixed spleen cells: ability to stimulate in the mixed lymphocyte reaction and generate effector cells in cell-mediated lympholysis.
    Lightbody JJ; Kong YM
    J Immunol; 1976 Oct; 117(4):1336-9. PubMed ID: 135809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific adsorption of cytotoxic thymus-processed lymphocytes (T cells) on glutaraldehyde-fixed fibroblast monolayers.
    Golstein P; Svedmyr EA; Blomgren H
    Eur J Immunol; 1972 Aug; 2(4):380-3. PubMed ID: 4628413
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
    Dennert G; Hatlen LE
    J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Tumor-like assay conditions, lonizing radiation, and hyperthermia on immune lysis of tumor cells by cytotoxic T-lymphocytes.
    Harris JW
    Cancer Res; 1976 Aug; 36(8):2733-9. PubMed ID: 6145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effects of antigen- and mitogen-induced T cells on various targets.
    Bevan MJ; Cohn M
    J Immunol; 1975 Feb; 114(2 Pt 1):559-65. PubMed ID: 123541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between proliferative and effector phases of the mixed lymphocyte reaction and graft-vs-host reaction.
    Howe M; Berman L; Cohen L
    J Immunol; 1973 Oct; 111(4):1243-9. PubMed ID: 4147022
    [No Abstract]   [Full Text] [Related]  

  • 12. Hapten-specific T lymphocyte activation by glutaraldehyde-treated macrophages: an argument against antigen processing by macrophages.
    Thomas DW
    J Immunol; 1978 Nov; 121(5):1760-6. PubMed ID: 152327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
    Williams RM; Germain RN; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.
    Greenberg AH; Shen L; Medley G
    Immunology; 1975 Oct; 29(4):719-29. PubMed ID: 810417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA of human Raji target cells is damaged upon lymphocyte-mediated lysis.
    Gromkowski SH; Brown TC; Cerutti PA; Cerottini JC
    J Immunol; 1986 Feb; 136(3):752-6. PubMed ID: 3079799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An effector-cell independent step in target cell lysis by sensitized mouse lymphocytes.
    Martz E; Benacerraf B
    J Immunol; 1973 Nov; 111(5):1538-45. PubMed ID: 4200780
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetic analysis of target cell destruction by effector T cells. I. Delineation of parameters related to the frequency and lytic efficiency of killer cells.
    Thorn RM; Henney CS
    J Immunol; 1976 Dec; 117(6):2213-9. PubMed ID: 825577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.